Serotonin in depression is highly relevant in diagnosis, treatment, and drug development. To better study this area, a Chinese team has now developed a fluorescent probe for imaging processes that is ...

Researchers say exercise may be just as beneficial as medication, but caution that more studies are needed ...

In a report scheduled for publication in the June 2023 issue of the Journal of Affective Disorders, researchers explore the association between the gut microbiome and the efficacy of selective ...

A large Australian study showed atypical depression has distinct genetic, clinical, and treatment-response features. Read ...

Drugs that target the neurotransmitter serotonin have long been prescribed to treat depression. Now the spotlight is turning to other aspects of brain chemistry. In this episode, the ...

For the last half-century, the dominant explanation for depression has centered on serotonin. The basic idea: low levels of brain serotonin or serotonin activity lead to symptoms of depression. This ...

Serotonin is a common target for pharmaceuticals designed to treat depression and anxiety. The psychedelic effects of psilocybin stem from the serotonin receptor 2A, Nautiyal explains.

The neurotransmitter serotonin, released in a brain structure called the habenula, is the key molecule mediating resilience. Image shows neurons within the mouse habenula. Human beings have the ...

Psychedelics, psychoactive substances that alter people's perceptions, mood and thought patterns, have recently shown promise for the treatment of some mental health disorders, including depression ...

Serotonergic neurons release serotonin when they sense high levels of glucose. This triggers the activation of the kisspeptin neurons, the primary stimulator for releasing reproductive hormones.